Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Stroke

  Free Subscription


Articles published in Lancet Neurol

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    February 2018
  1. GALOVIC M, Dohler N, Erdelyi-Canavese B, Felbecker A, et al
    Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study.
    Lancet Neurol. 2018;17:143-152.
    PubMed     Text format     Abstract available


    January 2018
  2. RODRIGUES MA, Samarasekera N, Lerpiniere C, Humphreys C, et al
    The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study.
    Lancet Neurol. 2018 Jan 10. pii: S1474-4422(18)30006.
    PubMed     Text format     Abstract available


  3. CAMPBELL BCV, van Zwam WH, Goyal M, Menon BK, et al
    Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.
    Lancet Neurol. 2018;17:47-53.
    PubMed     Text format     Abstract available


  4. DINSMORE J
    HERMES: a helpful messenger in the anaesthesia for thrombectomy debate?
    Lancet Neurol. 2018;17:21-23.
    PubMed     Text format    


    November 2017
  5. CORLEY J
    Telestroke: India's solution to a public health-care crisis.
    Lancet Neurol. 2017 Nov 29. pii: S1474-4422(17)30423.
    PubMed     Text format    


    October 2017
  6. STINEAR CM
    Prediction of motor recovery after stroke: advances in biomarkers.
    Lancet Neurol. 2017;16:826-836.
    PubMed     Text format     Abstract available


  7. WILSON L, Stewart W, Dams-O'Connor K, Diaz-Arrastia R, et al
    The chronic and evolving neurological consequences of traumatic brain injury.
    Lancet Neurol. 2017;16:813-825.
    PubMed     Text format     Abstract available


    September 2017
  8. FINSTERER J
    Low risk of ischaemic stroke in hyperhomocysteinaemia.
    Lancet Neurol. 2017;16:682-683.
    PubMed     Text format    


  9. SPENCE JD, Yi Q, Hankey GJ
    B vitamins in stroke prevention: time to reconsider.
    Lancet Neurol. 2017;16:750-760.
    PubMed     Text format     Abstract available


  10. VAN VELUW SJ, Shih AY, Smith EE, Chen C, et al
    Detection, risk factors, and functional consequences of cerebral microinfarcts.
    Lancet Neurol. 2017;16:730-740.
    PubMed     Text format     Abstract available


    August 2017
  11. ANDERSON CS
    NOR-TEST-ing tenecteplase in acute ischaemic stroke.
    Lancet Neurol. 2017 Aug 8. pii: S1474-4422(17)30277.
    PubMed     Text format    


  12. LOGALLO N, Novotny V, Assmus J, Kvistad CE, et al
    Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Lancet Neurol. 2017 Aug 2. pii: S1474-4422(17)30253.
    PubMed     Text format     Abstract available


  13. MAEGELE M, Schochl H, Menovsky T, Marechal H, et al
    Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management.
    Lancet Neurol. 2017;16:630-647.
    PubMed     Text format     Abstract available


  14. SIHVONEN AJ, Sarkamo T, Leo V, Tervaniemi M, et al
    Music-based interventions in neurological rehabilitation.
    Lancet Neurol. 2017;16:648-660.
    PubMed     Text format     Abstract available


    July 2017
  15. WACHTER R, Groschel K
    Atrial fibrillation in high-risk patients with ischaemic stroke - Authors' reply.
    Lancet Neurol. 2017;16:498.
    PubMed     Text format    


  16. KNECHT S, Petsch S, Studer B
    Atrial fibrillation in high-risk patients with ischaemic stroke.
    Lancet Neurol. 2017;16:498.
    PubMed     Text format    


    May 2017
  17. BERGE E, Salman RA, van der Worp HB, Stapf C, et al
    Increasing value and reducing waste in stroke research.
    Lancet Neurol. 2017;16:399-408.
    PubMed     Text format     Abstract available


    March 2017
  18. HESS DC, Wechsler LR, Clark WM, Savitz SI, et al
    Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet Neurol. 2017 Mar 17. pii: S1474-4422(17)30046.
    PubMed     Text format     Abstract available


  19. DAVALOS A, Cobo E, Molina CA, Chamorro A, et al
    Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.
    Lancet Neurol. 2017 Mar 16. pii: S1474-4422(17)30047.
    PubMed     Text format     Abstract available


  20. FASSBENDER K, Grotta JC, Walter S, Grunwald IQ, et al
    Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.
    Lancet Neurol. 2017;16:227-237.
    PubMed     Text format     Abstract available


  21. ELKINS J, Veltkamp R, Montaner J, Johnston SC, et al
    Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial.
    Lancet Neurol. 2017;16:217-226.
    PubMed     Text format     Abstract available


  22. TATLISUMAK T
    Can natalizumab be beneficial in acute ischaemic stroke?
    Lancet Neurol. 2017;16:176-177.
    PubMed     Text format    


    February 2017
  23. AMARENCO P, Albers GW, Denison H, Easton JD, et al
    Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Lancet Neurol. 2017 Feb 23. pii: S1474-4422(17)30038.
    PubMed     Text format     Abstract available


  24. WACHTER R, Groschel K, Gelbrich G, Hamann GF, et al
    Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.
    Lancet Neurol. 2017 Feb 7. pii: S1474-4422(17)30002.
    PubMed     Text format     Abstract available


  25. BRACARD S, Ducrocq X, Guillemin F, Moulin T, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke - Authors' reply.
    Lancet Neurol. 2017;16:104.
    PubMed     Text format    


  26. BADHIWALA JH, Nassiri F, Kulkarni AV, Spears J, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
    Lancet Neurol. 2017;16:103.
    PubMed     Text format    


  27. MORELLI N, Rota E, Michieletti E, Guidetti D, et al
    Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke.
    Lancet Neurol. 2017;16:103-104.
    PubMed     Text format    


    November 2016
  28. KELLY PJ, Albers GW, Chatzikonstantinou A, De Marchis GM, et al
    Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.
    Lancet Neurol. 2016;15:1238-1247.
    PubMed     Text format     Abstract available


  29. HANLEY DF, Thompson RE, Muschelli J, Rosenblum M, et al
    Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
    Lancet Neurol. 2016;15:1228-1237.
    PubMed     Text format     Abstract available


    October 2016
  30. TANG M, Ryman DC, McDade E, Jasielec MS, et al
    Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30229.
    PubMed     Text format     Abstract available


    April 2016
  31. KIRBY T
    Philip B Gorelick: changing neurological practice in the USA.
    Lancet Neurol. 2016;15:361.
    PubMed     Text format    


  32. BURTON A
    South Africa: stroke units out of the blue.
    Lancet Neurol. 2016;15:359-60.
    PubMed     Text format    


    January 2016
  33. MUIR KW
    Stroke in 2015: the year of endovascular treatment.
    Lancet Neurol. 2016;15:2-3.
    PubMed     Text format    


    December 2015
  34. MARSHALL IJ, Wang Y, Crichton S, McKevitt C, et al
    The effects of socioeconomic status on stroke risk and outcomes.
    Lancet Neurol. 2015;14:1206-1218.
    PubMed     Text format     Abstract available


    November 2015
  35. PITKANEN A, Roivainen R, Lukasiuk K
    Development of epilepsy after ischaemic stroke.
    Lancet Neurol. 2015 Nov 13. pii: S1474-4422(15)00248.
    PubMed     Text format     Abstract available


    October 2015
  36. KWAKKEL G, Meskers CG
    Botulinum toxin A for upper limb spasticity.
    Lancet Neurol. 2015;14:969-71.
    PubMed     Text format    


    September 2015
  37. BURTON A
    Peter Rothwell: aspirin(g) physician with a little stroke of genius.
    Lancet Neurol. 2015;14:878.
    PubMed     Text format    


  38. COMPTER A, van der Worp HB, Algra A, Kappelle LJ, et al
    Risks of stenting in patients with extracranial and intracranial vertebral artery stenosis.
    Lancet Neurol. 2015;14:875.
    PubMed     Text format    


  39. WU CY, Chang KC
    Constraint-induced movement therapy translated into practice.
    Lancet Neurol. 2015;14:869-71.
    PubMed     Text format    


    August 2015
  40. GRACIES JM, Brashear A, Jech R, McAllister P, et al
    Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Lancet Neurol. 2015 Aug 26. pii: S1474-4422(15)00216.
    PubMed     Text format     Abstract available


    July 2015
  41. BARZEL A, Ketels G, Stark A, Tetzlaff B, et al
    Home-based constraint-induced movement therapy for patients with upper limb dysfunction after stroke (HOMECIMT): a cluster-randomised, controlled trial.
    Lancet Neurol. 2015 Jul 28. pii: S1474-4422(15)00147.
    PubMed     Text format     Abstract available


  42. LI L, Yiin GS, Geraghty OC, Schulz UG, et al
    Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.
    Lancet Neurol. 2015 Jul 27. pii: S1474-4422(15)00132.
    PubMed     Text format     Abstract available


  43. FERRO JM
    Ischaemic stroke of undetermined cause.
    Lancet Neurol. 2015 Jul 27. pii: S1474-4422(15)00149.
    PubMed     Text format    


  44. FISHER M, Saver JL
    Future directions of acute ischaemic stroke therapy.
    Lancet Neurol. 2015;14:758-67.
    PubMed     Text format     Abstract available


  45. SANDERCOCK PA
    A call to revolutionise acute stroke care and research.
    Lancet Neurol. 2015;14:674-5.
    PubMed     Text format    


    June 2015
  46. CAMPBELL BC, Donnan GA, Lees KR, Hacke W, et al
    Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke.
    Lancet Neurol. 2015 Jun 25. pii: S1474-4422(15)00140.
    PubMed     Text format     Abstract available


  47. TURAN TN, Chimowitz MI
    Yet again no benefit of stenting over medical therapy.
    Lancet Neurol. 2015;14:565-6.
    PubMed     Text format    


  48. COMPTER A, van der Worp HB, Schonewille WJ, Vos JA, et al
    Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial.
    Lancet Neurol. 2015;14:606-14.
    PubMed     Text format     Abstract available


    April 2015
  49. ALBERS GW, von Kummer R, Truelsen T, Jensen JK, et al
    Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Lancet Neurol. 2015 Apr 30. pii: S1474-4422(15)00047.
    PubMed     Text format     Abstract available


  50. HILL MD, Menon BK
    Desmoteplase for late treatment of stroke: still in the dark.
    Lancet Neurol. 2015 Apr 30. pii: S1474-4422(15)00061.
    PubMed     Text format    


  51. KASNER SE
    CADISS: a feasibility trial that answered its question.
    Lancet Neurol. 2015;14:342-3.
    PubMed     Text format    


  52. MARKUS HS, Hayter E, Levi C, Feldman A, et al
    Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.
    Lancet Neurol. 2015;14:361-7.
    PubMed     Text format     Abstract available


    March 2015

  53. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial.
    Lancet Neurol. 2015 Mar 26. pii: S1474-4422(15)00012.
    PubMed     Text format     Abstract available


  54. LARRUE V
    Brain CT signs and the effect of alteplase after stroke.
    Lancet Neurol. 2015 Mar 26. pii: S1474-4422(15)00013.
    PubMed     Text format    


  55. THE LANCET NEUROLOGY
    The stroke care revolution.
    Lancet Neurol. 2015 Mar 5. pii: S1474-4422(15)70023.
    PubMed     Text format    


  56. SPOSATO LA, Cipriano LE, Saposnik G, Vargas ER, et al
    Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.
    Lancet Neurol. 2015 Mar 3. pii: S1474-4422(15)70027.
    PubMed     Text format     Abstract available


  57. ABDUL-RAHIM AH, Lees KR
    Screening for atrial fibrillation after stroke or TIA.
    Lancet Neurol. 2015 Mar 3. pii: S1474-4422(15)70039.
    PubMed     Text format    


    February 2015
  58. SCHWAMM LH
    Breaking up is hard to do: tenecteplase in acute stroke.
    Lancet Neurol. 2015 Feb 25. pii: S1474-4422(15)70036.
    PubMed     Text format    


  59. HUANG X, Cheripelli BK, Lloyd SM, Kalladka D, et al
    Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Lancet Neurol. 2015 Feb 25. pii: S1474-4422(15)70017.
    PubMed     Text format     Abstract available


  60. KWAKKEL G, Veerbeek JM, van Wegen EE, Wolf SL, et al
    Constraint-induced movement therapy after stroke.
    Lancet Neurol. 2015;14:224-234.
    PubMed     Text format     Abstract available


    January 2015
  61. KIRTON A, deVeber G
    Paediatric stroke: pressing issues and promising directions.
    Lancet Neurol. 2015;14:92-102.
    PubMed     Text format     Abstract available


  62. GORELICK PB, Farooq MU
    Stroke: an emphasis on guidelines.
    Lancet Neurol. 2015;14:2-3.
    PubMed     Text format    


    December 2014

  63. Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial.
    Lancet Neurol. 2014;13:1186-92.
    PubMed     Text format     Abstract available


  64. PEARCE LA, McClure LA, Anderson DC, Jacova C, et al
    Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
    Lancet Neurol. 2014;13:1177-85.
    PubMed     Text format     Abstract available


  65. KOHLER S, Hackett ML, O'Brien JT, Mead GE, et al
    Neuropsychiatric outcomes after stroke - Authors' reply.
    Lancet Neurol. 2014;13:1168-9.
    PubMed     Text format    


  66. KALLIO ME
    Neuropsychiatric outcomes after stroke.
    Lancet Neurol. 2014;13:1168.
    PubMed     Text format    


  67. HANKEY GJ
    Intermittent pneumatic compression after stroke.
    Lancet Neurol. 2014;13:1163-5.
    PubMed     Text format    


  68. HILLIS AE
    Blood pressure control after stroke: too little, too late, or too soon to tell?
    Lancet Neurol. 2014;13:1162-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: